Our Location | Contact Us | Careers

TGaS® Advisors provides pharmaceutical companies with tools for continuous improvement, and with fact-based answers to the question: “How do other pharmaceutical companies do ‘it’?”®


Press Release

Commercial Compliance Benchmark Charts Promotional Monitoring by Pharmaceutical Companies

TGaS® Advisors Provides Landscape Analysis on Key Compliance Issue


East Norriton, Penn., June 29, 2009 — Promotional monitoring is one of the pharmaceutical industry’s toughest challenges. A recent benchmark, conducted by TGaS® Advisors Commercial Compliance Practice, found that pharmaceutical companies are using several methods to check for regulatory compliance by sales representatives, including “ride-alongs,” audits of physician message recall and sampling and expense account monitoring

TGaS Advisors, a leader in benchmarking and advisory services to the pharmaceutical industry, conducted the targeted, peer-set benchmark among heads of Commercial Compliance Groups at 12 of the top pharmaceutical companies. The goal was to learn how companies are handling this issue and create a confidential industry landscape analysis for clients. Key findings:

  • All study participants monitor promotional efforts of sales representatives.
  • “Ride-alongs” are one key audit method for two-thirds of the participating companies. District Managers (25%), Regional Managers (17%), Home Office compliance staff (33%) or contract personnel (less than 10%) accompany sales representatives and audit sales calls.
  • A second method audits physicians for message recall data. Three-quarters of the companies conduct these audits, mostly using outside market research.
  • All companies monitor expense reports for promotional issues and 75% audit sampling. Companies are also training their compliance officers to conduct these audits. In general, companies devote about a day to training, and more than half is in-person. One company requires a week (40 hours) of training.

According to Stephen E. Gerard, Managing Partner, the TGaS Advisors 2009 Annual State of Pharmaceutical Commercial Operations Benchmark predicted that compliance would be one of the areas of greatest change this year. “Regulatory concerns are on everyone’s radar,” said Gerard. “Commercial Operations leaders are deeply conscious of compliance issues across the board, from sales calls to Internet marketing. Sharing information on promotional monitoring supports industry efforts to stay compliant in a time of flux.”

About TGaS® Advisors LLC

TGaS Advisors, ranked ninth among health-related companies by the Inc. 500, is the leader in benchmarking and advisory services to the pharmaceutical and biopharmaceutical industry. The TGaS Advisors roster includes nine of the top 10 and the majority of the top 50 pharmaceutical companies with operations in the U.S. market. The firm’s benchmarking and advisory services suite of solutions, PharmaStance®, provides clients with a way to measure where they stand with respect to their organizations and answers the question, “How do other pharmaceutical companies do ‘it’?”® TGaS Advisors is based in East Norriton, Pennsylvania.

Other 2009:
TGaS Advisors’ Gerard Featured on Executive Leaders Radio
TGaS Advisors Hosts Pharma Commercial Operations Summit on 2010 Trends
TGaS Advisors’ Donna Wray Invited to Present Benchmark Findings and Recommendations on Digital Marketing Issues at DDMAC Hearings
The Right Skill Sets for Pharma More Critical Than Ever in 2009, According to TGaS Advisors Organizational Career Guide
TGaS Advisors Sample Accountability Benchmark Shows Stepped-Up Focus on Compliance Operations
TGaS Advisors Named to Philadelphia 100®
Brian Deppen Joins TGaS Advisors Managed Markets Practice
Managed Markets Leaders Identify Most Urgent Concerns
TGaS Advisors Appoints Anthony Sorce, Vice President, New Business Development and Jeff Wojcik Promoted to Principal
TGaS Advisors Named to 2009 INC 500/5000, Ranked First in Business Products & Services in the Mid-Atlantic Region
Critical Job Skills, Career Progression are Key Issues for Sales Ops Leadership
Taking “Closed Loop” to the Next Level: Re-Imagining Sales and Managed Markets as an Interactive System
TGaS Advisors Convenes “Mega-Summit” for Pharma Leaders on the Impact of Industry Trends on Commercial Organizations
FDA Letters Hobble a Favorite Relationship Marketing Tactic of TGaS Advisors Benchmark Companies Page
TGaS Advisors Analytics Experts Urge Pharma Management Sciences Professionals to Help Shape Industry Future
TGaS Advisors Appoints Curt Staab Director, Management Advisor, Sales Advisory Practice
TGaS Advisors Offers Benchmark-based Services to Support Integration Following Recent Wave of Mergers & Acquisitions
TGaS Advisors Introduces Commercial Compliance Benchmark